Scientific overview of exceptional responders in cancer research

Scientific overview of exceptional responders in cancer research The passage is a general, historical discussion of medical case studies and advances in cancer genomics with no mention of influential actors, financial flows, or misconduct. It offers no actionable investigative leads. Key insights: Describes the concept of "exceptional responders" in oncology.; References historical cases like Phineas Gage, Edward Jenner, and the Berlin patient.; Summarizes how genomic sequencing has enabled targeted cancer therapies such as gefitinib and sorafenib.